AES 2024

We are delighted to announce SynapCell’s participation in the American Epilepsy Society (AES) 2024 Annual Meeting, to be held December 6-10 in Los Angeles, booth #2141. 

As a leading preclinical CRO specializing in CNS EEG for over 20 years, we invite you to discover how our preclinical EEG expertise can accelerate your Epilepsy drug discovery process. During the conference:

• We will unveil new preclinical EEG capabilities for Epilepsy drug discovery with our Amygdala-Kindling rat model: This new rat model specifically targets Focal to Generalized Epilepsy, complementing our reference models MTLE and GAERS (Genetic Absence Epilepsy Rat from Stratsbourg) for Mesial Temporal Epilepsy and Generalized Absence Epilepsy respectively. 
  
  SynapCell holds the world-exclusive license for the GAERS model.
  
  

• Find out more about Cue®, SynapCell’s translational and predictive in vivo EEG platform. Cue® is the result of over 20+ years of R&D, combining SynapCell’s know-how, expertise and scientific excellence in neuroscience, brain surgery, EEG signal processing and analysis, and pharmacology.

Meet our scientists at booth #2141 and let’s talk Science and your specific challenges.